<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01041209</url>
  </required_header>
  <id_info>
    <org_study_id>HGNPE-186</org_study_id>
    <nct_id>NCT01041209</nct_id>
  </id_info>
  <brief_title>Bacterial Pneumonia Score (BPS) Guided Antibiotic Use in Children With Community Acquired Pneumonia</brief_title>
  <official_title>Efficacy of BPS (Bacterial Pneumonia Score) Guided Antibiotic Use in Children With Community Acquired Pneumonia on Reducing Antibiotic Use as Compared to Standard Care Practice (Current Guidelines for CAP)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital General de Niños Pedro de Elizalde</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital General de Niños Pedro de Elizalde</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to test if BPS (Bacterial Pneumonia Score) guided antibiotic use in
      children with non severe community acquired pneumonia (CAP) will reduce antibiotic use as
      compared to standard care practice (current guidelines for CAP).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background: Pneumonia is a leading cause of mortality in children. Despite more than 50% of
      pneumonias are due to viruses, because it is difficult to rule out bacterial etiology,
      initial management of pneumonia in children usually includes antibiotics, often unnecessary.
      In 2006 was designed and validated a clinical prediction rule (BPS: Bacterial Pneumonia
      Score) which accurately identifies hospitalized children's risk of bacterial pneumonia.
      However, BPS efficacy on guiding therapeutic decision in children with community acquired
      pneumonia (CAP) has not been yet assessed.

      Aim: The aim of this study is to test if BPS guided antibiotic use in children with non
      severe community acquired pneumonia will reduce antibiotic use as compared to standard care
      practice (current guidelines for CAP) Design: This is a randomized, controlled, blinded
      trial, to assess antibiotics use regarding two methods for initial management of children
      aged 3-60 months with non severe community acquired pneumonia. Children will be randomly
      allocate to be managed according to BPS or currently enforced guidelines. Use of antibiotics
      (%) and clinical outcome of both groups will be compared.

      Setting: Tertiary children hospital in Buenos Aires, Argentina. Patients: Consecutive
      children aged 3-60 months assisted for non severe community acquired pneumonia as
      outpatients. Patients with wheezing, severe pneumonia, pulmonary or cardiovascular chronic
      disease, or antibiotic use or hospitalization in the previous two weeks will be excluded.

      Endpoints:

      Primary: Use of antibiotics in each group (proportion) Secondary: Treatment failure
      (proportion) in each group Endpoints will be assessed at baseline and after 1, 2, 5, 7 and 10
      days by a blinded investigator.

      Intervention: Patients with CAP will be randomized (1:1) to BPS versus enforced guidelines.
      In the BPS group antibiotics will be indicated in patients with a BPS ≥ 4 points, while in
      the control group antibiotics will be indicated according to current guidelines.

      Variables and measurement: Antibiotic use will be defined as initial use of any antibiotic,
      immediately after diagnosis. Treatment failure will be defined as persistence of fever after
      2 days, or tachypnea or diminishing in respiratory rate less than 5 bpm. after 2 days, or
      signs of severe pneumonia or requiring or changing antibiotics at any time.

      Study hypothesis: BPS antibiotic use guidance will reduce at least 20% antibiotic use, as
      compared to standard care practice.

      Analyses: These will be done based on an intention-to-treat and a per-protocol principle.
      With an assumed 20% less use of antibiotics in the intervention group, a maximum of 5% losses
      to follow-up, a confidence of 5% and power of 90%, the total sample size is 60. This will
      allow detecting a difference in clinical outcome of 28%. Proportion will be compared by Chi
      square test.

      Interim monitoring: Regular review of serious adverse events, quality and integrity of the
      study by an independent data safety and monitoring board. Safety interim analysis after 50%
      of the patients recruited.

      Significance: Due to the high prevalence of CAP in children, this study will offer the
      potential for a substantial reduction in health costs and antibiotics resistance.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2010</start_date>
  <completion_date type="Actual">March 2012</completion_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Use of Antibiotics in Each Group</measure>
    <time_frame>At baseline</time_frame>
    <description>The proportion of patients receiving antibiotics was compared between both groups (BPS vs Guidelines).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Treatment Failure in Each Group</measure>
    <time_frame>1, 2, 5, 7 and 10 days from baseline</time_frame>
    <description>Treatment failure was defined as: Persistence of fever after 2 days, or tachypnea or diminishing in respiratory rate less than 5 bpm after 2 days, or signs of severe pneumonia or requiring or changing antibiotics at any time.
Proportion of patients with treatment failure was compared between both groups (BPS vs Guideline).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Pneumonia</condition>
  <arm_group>
    <arm_group_label>BPS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>BPS guidance</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Guideline</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Enforced guidelines</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Strategy based on BPS guided antibiotic use</intervention_name>
    <description>In this study a strategy based on BPS guided antibiotic use in children with community acquired pneumonia implementation will be compared with enforced guideline.</description>
    <arm_group_label>BPS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Enforced Guidelines</intervention_name>
    <description>In this study a strategy based on BPS guided antibiotic use in children with community acquired pneumonia implementation will be compared with enforced guideline.</description>
    <arm_group_label>Guideline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children aged 3-60 months assisted as outpatients for non severe community acquired
             pneumonia.

        Exclusion Criteria:

          -  Wheezing

          -  Severe pneumonia

          -  Pulmonary or cardiovascular chronic disease

          -  Antibiotic use in the previous two weeks

          -  Hospitalization for any reason in the previous two weeks
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>60 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fernando A Torres, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital General de Niños Pedro de Elizalde</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital General de Niños Pedro de Elizalde</name>
      <address>
        <city>Buenos Aires</city>
        <state>Caba</state>
        <zip>C1270AAN</zip>
        <country>Argentina</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Argentina</country>
  </location_countries>
  <reference>
    <citation>Moreno L, Krishnan JA, Duran P, Ferrero F. Development and validation of a clinical prediction rule to distinguish bacterial from viral pneumonia in children. Pediatr Pulmonol. 2006 Apr;41(4):331-7. Erratum in: Pediatr Pulmonol. 2006 May;41(5):494.</citation>
    <PMID>16493666</PMID>
  </reference>
  <reference>
    <citation>Ferrero F, Torres F, Noguerol E, González N, Lonegro L, Chiolo MJ, Ossorio MF, Benguigui Y. [Evaluation of two standardized methods for chest radiographs interpretation in children with pneumonia]. Arch Argent Pediatr. 2008 Dec;106(6):510-4. doi: 10.1590/S0325-00752008000600007. Spanish.</citation>
    <PMID>19107303</PMID>
  </reference>
  <results_reference>
    <citation>Torres FA, Pasarelli I, Cutri A, Ossorio MF, Ferrero F. Impact assessment of a decision rule for using antibiotics in pneumonia: a randomized trial. Pediatr Pulmonol. 2014 Jul;49(7):701-6. doi: 10.1002/ppul.22849. Epub 2013 Aug 23.</citation>
    <PMID>24039234</PMID>
  </results_reference>
  <verification_date>June 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 30, 2009</study_first_submitted>
  <study_first_submitted_qc>December 30, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 31, 2009</study_first_posted>
  <results_first_submitted>June 29, 2012</results_first_submitted>
  <results_first_submitted_qc>August 27, 2012</results_first_submitted_qc>
  <results_first_posted type="Estimate">September 27, 2012</results_first_posted>
  <last_update_submitted>November 7, 2016</last_update_submitted>
  <last_update_submitted_qc>November 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 28, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pneumonia</keyword>
  <keyword>Children</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pneumonia</mesh_term>
    <mesh_term>Pneumonia, Bacterial</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Bacterial Pneumonia Score (BPS)</title>
          <description>Use of antibiotics according to Bacterial Pneumonia Score (BPS) guidance (antibiotic use when BPS &gt; or = 4 points)</description>
        </group>
        <group group_id="P2">
          <title>Guideline</title>
          <description>Use of antibiotics according to local enforced guidelines</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="60"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Bacterial Pneumonia Score (BPS)</title>
          <description>Bacterial Pneumonia Score (BPS) guidance</description>
        </group>
        <group group_id="B2">
          <title>Guideline</title>
          <description>Enforced guidelines</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="60"/>
            <count group_id="B2" value="60"/>
            <count group_id="B3" value="120"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="120"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="22.4" spread="13.2"/>
                    <measurement group_id="B2" value="26.1" spread="13.2"/>
                    <measurement group_id="B3" value="24.2" spread="14.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="63"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="27"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="57"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Argentina</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60"/>
                    <measurement group_id="B2" value="60"/>
                    <measurement group_id="B3" value="120"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Use of Antibiotics in Each Group</title>
        <description>The proportion of patients receiving antibiotics was compared between both groups (BPS vs Guidelines).</description>
        <time_frame>At baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bacterial Pneumonia Score (BPS)</title>
            <description>Indication of antibiotics according to Bacterial Pneumonia Score (BPS) guidance. Antibiotics were indicated with BPS &gt;= 4 points</description>
          </group>
          <group group_id="O2">
            <title>Guideline</title>
            <description>Indication of antibiotics according to local (Hospital) guidelines</description>
          </group>
        </group_list>
        <measure>
          <title>Use of Antibiotics in Each Group</title>
          <description>The proportion of patients receiving antibiotics was compared between both groups (BPS vs Guidelines).</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="28"/>
                    <measurement group_id="O2" value="52"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Treatment Failure in Each Group</title>
        <description>Treatment failure was defined as: Persistence of fever after 2 days, or tachypnea or diminishing in respiratory rate less than 5 bpm after 2 days, or signs of severe pneumonia or requiring or changing antibiotics at any time.
Proportion of patients with treatment failure was compared between both groups (BPS vs Guideline).</description>
        <time_frame>1, 2, 5, 7 and 10 days from baseline</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Bacterial Pneumonia Score (BPS)</title>
            <description>Indication of antibiotics according to Bacterial Pneumonia Score (BPS) guidance. Antibiotics were indicated with BPS &gt;= 4 points</description>
          </group>
          <group group_id="O2">
            <title>Guideline</title>
            <description>Indication of antibiotics according to local (Hospital)guidelines.</description>
          </group>
        </group_list>
        <measure>
          <title>Treatment Failure in Each Group</title>
          <description>Treatment failure was defined as: Persistence of fever after 2 days, or tachypnea or diminishing in respiratory rate less than 5 bpm after 2 days, or signs of severe pneumonia or requiring or changing antibiotics at any time.
Proportion of patients with treatment failure was compared between both groups (BPS vs Guideline).</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="60"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="5"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Bacterial Pneumonia Score (BPS)</title>
          <description>Bacterial Pneumonia Score (BPS) guidance</description>
        </group>
        <group group_id="E2">
          <title>Guideline</title>
          <description>Enforced guidelines</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Fernando Torres</name_or_title>
      <organization>Hospital General de Niños Pedro de Elizalde</organization>
      <phone>+54 11 43070140</phone>
      <email>slaip@intramed.net</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

